These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21501330)

  • 41. Recurrent fever associated with progesterone action and persistently elevated serum levels of immunoreactive tumor necrosis factor-alpha and interleukin-6.
    Rutanen EM; Teppo AM; Stenman UH; Tiitinen A; Fyhrquist F; Ylikorkala O
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1594-8. PubMed ID: 7684743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6.
    Abrahamsen B; Stilgren LS; Rettmer E; Bonnevie-Nielsen V; Beck-Nielsen H
    Calcif Tissue Int; 2003 Jan; 72(1):18-23. PubMed ID: 12384814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
    Balasch J; Fábregues F; Tur R; Creus M; Casamitjana R; Peñarrubia J; Barri PN; Vanrell JA
    Hum Reprod; 1995 Jun; 10(6):1377-81. PubMed ID: 7593500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fourteen-year-old girl with recurrent luteal-phase-dependent episodes of high fever.
    Yamasaki H; Oki T; Iwamoto I; Douchi T
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1166-8. PubMed ID: 21501330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
    DiLuigi AJ; Nulsen JC
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger.
    Engmann L; Benadiva C
    Semin Reprod Med; 2010 Nov; 28(6):506-12. PubMed ID: 21082510
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.